COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 847: Articles 8461-8470  | Next

Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea
Kim, H. N., Yoon, S. Y., Lim, C. S., Lee, C. K., Yoon, J.
10.1101/2022.03.15.484550 — Posted: 2022-03-16
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
Bowen, J. E., Sprouse, K. R., Walls, A. C., Mazzitelli, I. G., Logue, J. K., Franko, N. M., Ahmed, K., Shariq, A., Cameroni, E., Gori, A., Bori, A., Posavad, C. M., Dan, J. M., Zhang, Z., Weiskopf, D., Sette, A., Crotty, S., Talat Iqbal, N., Corti, D., Geffner, J., Grifantini, R., Chu, H. Y., Veesler, D.
10.1101/2022.03.15.484542 — Posted: 2022-03-16
Impact of COVID-19 on Life Expectancy among Native Americans
Goldman, N., Andrasfay, T.
10.1101/2022.03.15.22272448 — Posted: 2022-03-16
Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination
Amraotkar, A. R., Bushau-Sprinkle, A. M., Keith, R. J., Hamorsky, K. T., Palmer, K. E., Gao, H., Rai, S. N., Bhatnagar, A.
10.1101/2022.03.15.22272432 — Posted: 2022-03-16
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
Hochuli, J. E., Jain, S., Melo-Filho, C., Sessions, Z. L., Bobrowski, T., Choe, J., Zheng, J., Eastman, R., Talley, D. C., Rai, G., Simeonov, A., Tropsha, A., Muratov, E., Baljinnyam, B., Zakharov, A. V.
10.1101/2022.03.15.484484 — Posted: 2022-03-16
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2
Jana, I. D., Bhttacharya, P., Mayilsamy, K., Banerjee, S., Bhattacharje, G., Das, S., Aditya, S., Ghosh, A., McGill, A. R., Srikrishnan, S., Das, A. K., Basak, A., Mohapatra, S. S., Chandran, B., Bhimsaria, D., Mohapatra, S., Roy, A., Mondal, A.
10.1101/2022.03.16.484554 — Posted: 2022-03-16
Minimal SARS-CoV-2 classroom transmission at a large urban university experiencing repeated into campus introduction
Kuhfeldt, K. J., Turcinovic, J., Sullivan, M. L., Landaverde, L., Doucette-Stamm, L., Hamer, D. H., Platt, J., Klapperich, C. M., Landsberg, H. E., Connor, J.
10.1101/2022.03.16.22271983 — Posted: 2022-03-16
A conserved immune trajectory of recovery in hospitalized COVID-19 patients
Okholm, T. L. H., Burnett, C. E., Tenvooren, I., Marquez, D. M., Tamaki, S., Sandoval, P. M., The UCSF COMET Consortium, , Calfee, C. S., Hendrickson, C. M., Kangelaris, K. N., Langelier, C. R., Krummel, M. F., Woodruff, P. G., Erle, D. J., Ansel, K. M., Spitzer, M. H.
10.1101/2022.03.15.484467 — Posted: 2022-03-16
COVID-19 Vaccine Hesitancy among Marginalized Populations in the U.S. and Canada: Protocol for a Scoping Review
Newman, P. A., Reid, L., Tepjan, S., Fantus, S., Allan, K., Nyoni, T., Guta, A., Williams, C. C.
10.1101/2022.03.15.22272438 — Posted: 2022-03-16
No evidence for environmental transmission risk of SARS-CoV-2 in the UK's largest urban river system: London as a case study
Ransome, E., Hobbs, F., Jones, S., Coleman, C., Harris, D., Woodward, G., Bell, T., Trew, J., Kolarevic, S., Kracun-Kolarevic, M., Savolainen, V.
10.1101/2022.03.16.22272465 — Posted: 2022-03-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).